At least nine dominant neurodegenerative diseases are caused by expansion of CAG repeats in coding regions of specific genes that result in abnormal elongation of polyglutamine (polyQ) tracts in the corresponding gene products. When above a threshold that is specific for each disease the expanded polyQ repeats promote protein aggregation, misfolding and neuronal cell death. The length of the polyQ tract inversely correlates with the age at disease onset. It has been observed that interruption of the CAG tract by silent (CAA) or missense (CAT) mutations may strongly modulate the effect of the expansion and delay the onset age. We have carried out an extensive study in which we have complemented DNA sequence determination with cellular and bi...
Dynamic expansions of toxic polyglutamine (polyQ)-encoding CAG repeats in ubiquitously expressed, bu...
Polyglutamine repeat expansions of the CAG/CTG type frequently lead to disease characterized by prog...
The SPATAX NetworkInternational audienceObjectiveThe polyglutamine diseases, including Huntington's ...
At least nine dominant neurodegenerative diseases are caused by expansion of CAG repeats in coding r...
<div><p>At least nine dominant neurodegenerative diseases are caused by expansion of CAG repeats in ...
At least nine dominant neurodegenerative diseases are caused by expansion of CAG repeats in coding r...
<p>Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused b...
<p>Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused b...
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by a...
<p>Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused b...
Different aspects of expanded polyglutamine tracts and of their pathogenetic role are taken into con...
Polyglutamine (polyQ) disease is a group of neurodegenerative disorders caused by abnormal expansion...
It is known that in addition to repeat length variation, the exact sequence of the polyglutamine rep...
Identification of polymorphic repeating units on DNA as a cause of many neurological disorders has i...
Polyglutamine expansions, leading to aggregation, have been implicated in various neurodegenerative ...
Dynamic expansions of toxic polyglutamine (polyQ)-encoding CAG repeats in ubiquitously expressed, bu...
Polyglutamine repeat expansions of the CAG/CTG type frequently lead to disease characterized by prog...
The SPATAX NetworkInternational audienceObjectiveThe polyglutamine diseases, including Huntington's ...
At least nine dominant neurodegenerative diseases are caused by expansion of CAG repeats in coding r...
<div><p>At least nine dominant neurodegenerative diseases are caused by expansion of CAG repeats in ...
At least nine dominant neurodegenerative diseases are caused by expansion of CAG repeats in coding r...
<p>Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused b...
<p>Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused b...
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by a...
<p>Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused b...
Different aspects of expanded polyglutamine tracts and of their pathogenetic role are taken into con...
Polyglutamine (polyQ) disease is a group of neurodegenerative disorders caused by abnormal expansion...
It is known that in addition to repeat length variation, the exact sequence of the polyglutamine rep...
Identification of polymorphic repeating units on DNA as a cause of many neurological disorders has i...
Polyglutamine expansions, leading to aggregation, have been implicated in various neurodegenerative ...
Dynamic expansions of toxic polyglutamine (polyQ)-encoding CAG repeats in ubiquitously expressed, bu...
Polyglutamine repeat expansions of the CAG/CTG type frequently lead to disease characterized by prog...
The SPATAX NetworkInternational audienceObjectiveThe polyglutamine diseases, including Huntington's ...